CSI Market
Sign In | Register

Ambrx Biopharma Inc (AMAM) Annual Balance Sheets

Annual · GAAP · USD millions
Access AMAM quarterly Balance Sheets →
Tracking balance sheet results across Ambrx Biopharma Inc to helps illustrate how Dec 31 2022's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Dec 31 2021)
Assets
Cash & cash equivalent55.61
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments55.00
Accounts receivable0.38
Notes Receivable, Current1.51
Other Current Assets0.83
Prepaid Expense And Other Assets Current4.89
Total Current Assets90.58
Equipment/Property/Plant Net5.62
Intangible Assets-10.36
Long-term investments16.79
Tax Assets, Noncurrent0.45
Other Assets, Noncurrent2.00
Restricted Cash Current0.83
Operating Lease Right Of Use Asset10.97
Total Assets146.98
Liabilities
Accounts Payable, Current AC3.21
Accrued Liabilities, Current AC11.31
Other Liabilities, Current1.73
Taxes Payable4.73
Deferred Revenue, Current DE1.70
Total Current Liabilities16.66
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE1.34
Accrued Income Taxes, Noncurrent8.28
Other liabilities, Noncurrent11.13
Operating Lease Liability Current1.73
Operating Lease Liability Noncurrent10.25
Deferred Income Tax Liabilities Net0.88
Total Liabilities29.13
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock410.75
Retained Earnings / Accumulated Deficit-291.63
Accumulated Other Comprehensive Income-1.30
Other Equity-1.30
Common Stockholder's Equity117.85
Total Stockholder's Equity117.85
Liabilities & Stockholder's Equity146.98
4 historic quarters locked

Sign in to unlock the full Ambrx Biopharma Inc balance sheet history.

Sign In Create Free Account

About Ambrx Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-062916

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI